Elite Trades From Anywhere

$100 Off Your First Year

Claim Now
Last Close
3.79
Jun 30 • 03:22PM ET Dollar change-0.12 Percentage change(-3.20%)
Index
RUT
Market Cap
563.76M
Enterprise Value
421.58M
Income
30.70M
Sales
389.42M
Book/sh
1.63
Cash/sh
1.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
808
IPO
Aug 22, 2007
P/E
18.53
Forward P/E
47.88
PEG
-
P/S
1.45
P/B
2.32
P/C
3.53
P/FCF
8.13
EV/EBITDA
7.97
EV/Sales
1.08
Quick Ratio
4.81
Current Ratio
5.39
Debt/Eq
0.07
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
0.20
EPS next Y
0.08
EPS next Q
-0.03
EPS this Y
-117.97%
EPS next Y
237.50%
EPS next 5Y
-20.85%
EPS past 3/5Y
- -
Sales past 3/5Y
16.05% 11.02%
EPS Y/Y TTM
-23.96%
Sales Y/Y TTM
10.51%
EPS Q/Q
-256.08%
Sales Q/Q
-33.12%
Insider Own
20.98%
Insider Trans
0.00%
Inst Own
57.07%
Inst Trans
4.15%
ROA
10.60%
ROE
13.77%
ROIC
11.85%
Gross Margin
80.88%
Oper. Margin
10.17%
Profit Margin
7.88%
SMA20
1.80%
SMA50
5.05%
SMA200
-29.47%
Trades
Shs Outstand
148.93M
Shs Float
117.69M
52W High
7.99 -52.63%
52W Low
3.03 25.12%
Volatility
3.60% 3.61%
ATR (14)
0.14
RSI (14)
53.67
Beta
1.43
Rel Volume
0.51
Avg Volume
1.59M
Volume
731,135
Perf Week
1.47%
Perf Month
2.85%
Perf Quarter
-1.94%
Perf Half Y
-45.14%
Perf YTD
-44.09%
Perf Year
-38.05%
Perf 3Y
-42.74%
Perf 5Y
-69.74%
Perf 10Y
-52.57%
Prev Close
3.91
Price
3.79
Change
-3.20%
Date Action Analyst Rating Change Price Target Change
Feb-23-26Initiated Citizens Mkt Outperform $10
Jul-02-24Initiated Cantor Fitzgerald Overweight $11
Mar-07-24Initiated Lake Street Buy $12
Oct-27-23Initiated Craig Hallum Buy $12
Oct-13-22Initiated Mizuho Buy $7
Jul-26-21Initiated Northland Capital Outperform $23
Mar-19-21Initiated H.C. Wainwright Buy $20
Jun-02-26 09:00AM
May-21-26 08:45AM
May-08-26 08:00AM
Apr-30-26 03:16AM
Apr-29-26 04:55PM
04:01PM Loading…
04:01PM
Apr-28-26 09:26AM
Apr-22-26 08:00AM
Apr-16-26 08:00AM
Apr-02-26 09:15AM
Mar-23-26 08:00AM
Mar-05-26 08:00AM
Mar-01-26 03:20AM
Feb-26-26 12:07AM
12:05AM
07:25PM Loading…
Feb-25-26 07:25PM
04:42PM
04:01PM
Feb-24-26 07:28AM
Feb-17-26 08:00AM
Feb-04-26 10:27AM
Feb-02-26 03:27PM
08:00AM
Dec-22-25 09:43AM
Dec-19-25 09:00AM
Nov-17-25 09:55AM
Nov-13-25 08:00AM
Nov-10-25 04:01PM
Nov-03-25 09:15AM
Oct-31-25 09:55AM
05:25PM Loading…
Oct-29-25 05:25PM
04:23PM
04:01PM
Oct-28-25 09:50AM
Oct-15-25 08:00AM
Oct-06-25 09:28AM
Sep-03-25 08:00AM
Aug-29-25 05:11AM
Aug-27-25 08:00AM
Jul-31-25 03:32AM
Jul-30-25 05:40PM
04:50PM
04:01PM
08:00AM
Jul-29-25 09:50AM
Jul-16-25 09:15AM
08:00AM
Jul-15-25 09:15AM
Jul-14-25 05:22PM
Jul-09-25 09:36AM
May-27-25 08:00AM
May-14-25 06:00AM
May-06-25 08:00AM
May-05-25 08:30AM
May-01-25 11:03AM
03:18AM
Apr-30-25 09:52PM
05:15PM
04:19PM
04:01PM
Apr-16-25 08:00AM
Apr-10-25 04:01PM
Mar-31-25 05:45PM
Mar-20-25 01:58AM
Feb-27-25 08:22AM
08:00AM
02:22AM
Feb-26-25 05:55PM
05:04PM
04:01PM
Feb-25-25 10:37AM
Feb-05-25 08:00AM
Dec-17-24 09:00AM
Dec-04-24 08:00AM
Nov-20-24 09:55AM
Nov-14-24 09:15AM
Nov-04-24 09:55AM
08:00AM
Oct-31-24 05:00AM
Oct-30-24 05:25PM
04:26PM
04:01PM
Oct-14-24 08:00AM
Oct-09-24 03:36PM
Oct-08-24 04:01PM
Oct-01-24 04:01PM
Sep-11-24 01:03PM
Sep-04-24 04:23PM
Aug-27-24 08:00AM
Aug-26-24 09:30AM
Jul-31-24 04:22PM
04:02PM
04:01PM
Jul-22-24 08:10AM
Jul-17-24 08:00AM
08:00AM
Jul-01-24 02:18PM
Jun-26-24 04:01PM
May-20-24 06:00AM
May-15-24 08:00AM
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
CEO & DirectorMr. Joseph H. Capper
Chief Financial OfficerMr. Douglas C. Rice CPA
General Counsel & Chief Administrative OfficerMr. William F. Hulse IV
Chief Commercial OfficerMs. Kimberly Maersk-Moller
SVP of R&D & Medical Affairs and Chief Scientific OfficerDr. John Harper Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maersk-Moller KimberlyChief Commercial OfficerMar 10 '26Option Exercise4.5042,845192,802357,482Mar 12 05:37 PM
Hulse William Frank IVGeneral Counsel and CAOMar 10 '26Option Exercise4.50136,364613,638624,900Mar 12 05:35 PM
DOUG RICEChief Financial OfficerMar 10 '26Option Exercise4.50243,0001,093,500508,678Mar 12 05:34 PM
Maersk-Moller KimberlyChief Commercial OfficerNov 06 '25Sale7.4258,300432,329236,982Nov 10 05:14 PM
Kimberly Ann Maersk-MollerOfficerNov 06 '25Proposed Sale7.3368,587502,743Nov 06 04:14 PM